195 related articles for article (PubMed ID: 38636352)
1. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.
Colle R; Gressier F; Verstuyft C; Deflesselle E; Lépine JP; Ferreri F; Hardy P; Guilloux JP; Petit AC; Fève B; Falissard B; Becquemont L; Corruble E
J Affect Disord; 2015 Apr; 175():233-40. PubMed ID: 25658497
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder.
Ramesh V; Venkatesan V; Chellathai D; Silamban S
Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218
[TBL] [Abstract][Full Text] [Related]
4. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
[TBL] [Abstract][Full Text] [Related]
5. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
[TBL] [Abstract][Full Text] [Related]
6. Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.
Pathak P; Mehra A; Ram S; Pal A; Grover S
Behav Brain Res; 2022 Jul; 430():113931. PubMed ID: 35605794
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Katsuki A; Yoshimura R; Kishi T; Hori H; Umene-Nakano W; Ikenouchi-Sugita A; Hayashi K; Atake K; Iwata N; Nakamura J
CNS Spectr; 2012 Sep; 17(3):155-63. PubMed ID: 22883353
[TBL] [Abstract][Full Text] [Related]
8. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.
Hough CM; Lindqvist D; Epel ES; Denis MS; Reus VI; Bersani FS; Rosser R; Mahan L; Burke HM; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Mar; 77():122-130. PubMed ID: 28038403
[TBL] [Abstract][Full Text] [Related]
9. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
[TBL] [Abstract][Full Text] [Related]
10. Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.
Cheng CM; Hong CJ; Lin HC; Chu PJ; Chen MH; Tu PC; Bai YM; Chang WH; Juan CH; Lin WC; Tsai SJ; Su TP; Li CT
J Affect Disord; 2022 Jan; 297():353-359. PubMed ID: 34715162
[TBL] [Abstract][Full Text] [Related]
11. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
[TBL] [Abstract][Full Text] [Related]
12. The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression.
Tatham EL; Hall GB; Clark D; Foster J; Ramasubbu R
Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):135-147. PubMed ID: 27277475
[TBL] [Abstract][Full Text] [Related]
13. Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Hum Psychopharmacol; 2010 Mar; 25(2):145-52. PubMed ID: 20196181
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, inflammation and treatment response in major depression.
Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
[TBL] [Abstract][Full Text] [Related]
16. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.
Tsai SJ; Cheng CY; Yu YW; Chen TJ; Hong CJ
Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):19-22. PubMed ID: 14582140
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
[TBL] [Abstract][Full Text] [Related]
18. Serum BDNF levels before treatment predict SSRI response in depression.
Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
[TBL] [Abstract][Full Text] [Related]
19. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
